Shuang-jie Yu

Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients

Zheng Zhang, Hu Lin, Ming Shi et al. · Journal of Gastroenterology and Hepatology · 2012 · 386 citations

Medicine, Hematology, Internal Medicine +17

Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial

Ming Shi, Yuanyuan Li, Ruonan Xu et al. · Hepatology International · 2021 · 154 citations · Full text

Medicine, Pharmacotherapy, Cell Therapy +11

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial

Fanping Meng, Jinfang Zhao, Anthony T. Tan et al. · Hepatology International · 2021 · 108 citations · Full text

Medicine, Immunology, Oncology +16

[Prospective controlled trial of safety of human umbilical cord derived-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis].

Hu Lin, Zheng Zhang, Ming Shi et al. · PubMed · 2012 · 17 citations

Medicine, Hematology, Surgery +16

[Safety and efficacy of human umbilical cord derived-mesenchymal stem cell transplantation for treating patients with HBV-related decompensated cirrhosis].

Shuang-jie Yu, L M Chen, Sa Lyu et al. · PubMed · 2016 · 17 citations · Full text

Medicine, Hematology, Cell Therapy +14